•Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States
•A novel diagnostic serum protein signature for pediatric inflammatory bowel disease
•Building a Robust Investigator-Initiated Platform: The I-CARE Experience
•Intraluminal bypass devices as an alternative to defunctioning stoma in anterior resection: A systematic review of safety and feasibility
•Colon-targeted microbiota-modulating nanoparticles amplify azathioprine efficacy via gut microbiota axis remodeling in inflammatory bowel disease